
rau-sed
Pharmaranks rates Rau-Sed 3.6/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Rau-Sed (Reserpine) is a medication used to treat Hypertension, Schizophrenia, Dyskinesias.
Reserpine · by Bristol Myers Squibb
Available as a generic: Reserpine
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Reserpine
- Form
- Tablet
- Strength
- Reserpine 0.1MG · Reserpine 0.25MG · Reserpine 0.5MG · Reserpine 1MG
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- hypertension, schizophrenia, dyskinesias
- Manufacturer
- Bristol Myers Squibb
- FDA application
- NDA009357
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
- hypertension
- schizophrenia
- dyskinesias
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Rau-Sed treat?
- Rau-Sed (Reserpine) may be used to treat hypertension, schizophrenia, dyskinesias, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Rau-Sed rated?
- pharmaranks gives Rau-Sed a composite score of 3.6 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Rau-Sed?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Rau-Sed. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Rau-Sed?
- Rau-Sed is marketed by Bristol Myers Squibb. You can see Bristol Myers Squibb's full profile, rating, and other products on pharmaranks.
- Is Rau-Sed a brand-name or generic drug?
- Rau-Sed is a brand-name product with the active ingredient Reserpine. Lower-cost generic equivalents containing Reserpine are available — ask your pharmacist.
- Is Rau-Sed available over the counter?
- No. Rau-Sed is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Rau-Sed come in?
- Rau-Sed is currently marketed as tablet, per the FDA's National Drug Code Directory.
- Is Rau-Sed FDA-registered?
- Rau-Sed is on record with the U.S. FDA under application number NDA009357. You can verify this on its official FDA label.
- Has Rau-Sed been recalled by the FDA?
- Rau-Sed has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Rau-Sed safe?
- There's no single safe-or-not verdict. pharmaranks gives Rau-Sed a recall-safety score of 72/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about RESERPINE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 235 reports naming RESERPINE — the active ingredient in Rau-Sed, and the FDA flagged 84% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- gastrointestinal haemorrhage15 reports
- hypoglycaemia15 reports
- shock15 reports
- dyspnoea14 reports
- dizziness13 reports
- multiple organ dysfunction syndrome13 reports
- nausea12 reports
- fatigue11 reports
Read these as a signal, not a rate. A report does not mean RESERPINE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 26, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
amlodipine besylate
Amlodipine Besylate
aristada
Aripiprazole Lauroxil
aristada initio kit
Aripiprazole Lauroxil
atacand
Candesartan Cilexetil
bumex
Bumetanide
cardene
Nicardipine Hydrochloride
Compare Rau-Sed head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
rau-sed
72/100